Budget Amount *help |
¥5,460,000 (Direct Cost: ¥4,200,000、Indirect Cost: ¥1,260,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2012: ¥2,730,000 (Direct Cost: ¥2,100,000、Indirect Cost: ¥630,000)
|
Outline of Final Research Achievements |
In this study, we evaluated a biological functional of the CYP19 polymorphisms. The ratio of serum estrone/ androstenedione was significantly associated with the CYP19 polymorphisms and the polymorphisms altered the promoter activity of the CYP19 gene. Additionally, the cancer-specific survival of metastatic prostate cancer patients was significantly associated with the CYP19 polymorphisms. Those finding suggest that the CYP19 polymorphisms influence the risk and outcome of prostate cancer through the alteration in sex hormone milieu.
|